Assessment of health literacy and HPV knowledge among university students: An observational study
Elif Şenocak Taşçi,Dilşat Baş,Simge Kayak,Sema Anik,Aleyna Erözcan,Özlem Sönmez
DOI: https://doi.org/10.1097/md.0000000000039495
IF: 1.6
2024-09-02
Medicine
Abstract:Human papillomavirus (HPV) infection remains 1 of the most prevalent sexually transmitted infections worldwide, with approximately 14 million new cases annually, creating a significant burden on public health. [ 1 ] HPV is associated with a spectrum of conditions ranging from benign warts to malignancies, including cervical, anal, penile, and oropharyngeal cancers. In recent decades, the development and widespread adoption of HPV vaccines have offered a transformative approach to preventing HPV-related diseases. In 2006, the first HPV vaccine became available to prevent cervical cancer. [ 2 ] With growing evidence, 3 HPV vaccines (Gardasil 9, Gardasil, and Cervarix) were approved by the Food and Drug Administration for both females and males. [ 3 ] Although the recommended age for vaccination is 9 to 26 years, in 2019, the Centers for Disease Control and Prevention approved Gardasil 9 for men and women aged 29 to 45 years. This recent development is significant for preventing HPV-related cancers. However, despite the proven efficacy and safety of HPV vaccination, uptake rates remain suboptimal in many regions due to challenges such as financial constraints, concerns about safety, and limited healthcare access. [ 4 ] These barriers may be overcome by improving health literacy.
medicine, general & internal